HLB Pep Co., Ltd. Logo

HLB Pep Co., Ltd.

Biopharmaceutical firm specializing in peptide-based drug R&D and manufacturing.

196300 | KO

Overview

Corporate Details

ISIN(s):
KR7196300008
LEI:
Country:
South Korea
Address:
광주광역시 북구 첨단과기로 333 광주테크노파크 시험생산동 206호 , 광주광역시

Description

HLB Pep Co., Ltd. is a biopharmaceutical company specializing in the research, development, and production of peptide-based biomaterials and new drugs. The company's core activities include the manufacturing of peptide Active Pharmaceutical Ingredients (APIs) in a GMP-certified facility. It offers a range of products and services, including generic peptides, custom peptide synthesis for research and development, and a catalog of approximately 1,000 research peptides such as hormones and neuropeptides. HLB Pep focuses on discovering new drug candidates and aims to commercialize them through technology transfer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-03-30 00:00
주식등의대량보유상황보고서(일반)
Korean 81.6 KB
2023-03-29 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.2 KB
2023-03-27 00:00
정기주주총회결과
Korean 29.2 KB
2023-03-17 00:00
사업보고서 (2022.12)
Korean 1.1 MB
2023-03-17 00:00
감사보고서제출
Korean 17.7 KB
2023-02-28 00:00
[기재정정]주주총회소집공고
Korean 88.5 KB
2023-02-22 00:00
주주총회소집결의
Korean 16.1 KB
2023-02-22 00:00
주주총회소집공고
Korean 83.4 KB
2023-02-22 00:00
의결권대리행사권유참고서류
Korean 86.4 KB
2023-01-16 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 11.1 KB
2023-01-16 00:00
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 15.1 KB
2022-12-29 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 15.6 KB
2022-12-23 00:00
[기재정정]단일판매ㆍ공급계약체결
Korean 16.4 KB
2022-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2022-11-14 00:00
분기보고서 (2022.09)
Korean 939.7 KB

Automate Your Workflow. Get a real-time feed of all HLB Pep Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB Pep Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB Pep Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BELITE BIO, INC Logo
Clinical-stage biopharma developing therapies for retinal and metabolic diseases.
United States of America
BLTE
Benitec Biopharma Inc. Logo
A clinical-stage biotech developing genetic medicines to silence disease-causing genes.
United States of America
BNTC
BeOne Medicines Ltd. Logo
Global oncology company that discovers, develops, and delivers cancer treatments.
United States of America
ONC
BerGenBio Logo
Clinical-stage biopharma that developed selective AXL kinase inhibitors for cancer.
Norway
BGBIO
Beximco Pharmaceuticals Ltd. Logo
Manufacturer of generic drugs, APIs, and specialized products for global markets.
Bangladesh
BXP
BeyondSpring Inc. Logo
Clinical-stage biopharma company developing immuno-oncology cancer therapies.
United States of America
BYSI
BGM Group Ltd. Logo
A holding company focused on technology and biopharmaceutical manufacturing.
United States of America
BGM
Bicara Therapeutics Inc. Logo
Clinical-stage biopharma developing dual-action biologics for solid tumors.
United States of America
BCAX
BICYCLE THERAPEUTICS PLC Logo
Clinical-stage biopharma developing a novel class of bicyclic peptide medicines.
United States of America
BCYC
BIFIDO. Co. Ltd Logo
Biotechnology firm developing human-derived Bifidobacterium for various products.
South Korea
238200

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.